MedTrace Logo

Drug Interaction Study of Isavuconazole and Midazolam

NCT01406171 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2011-08-01

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of isavuconazole at steady state on the pharmacokinetics of midazolam in healthy adult subjects.

Conditions

  • Pharmacokinetics of Isavuconazole
  • Pharmacokinetics of Midazolam
  • Healthy Volunteers

Interventions

DRUG

Isavuconazole

oral

DRUG

Midazolam

Oral

Sponsors & Collaborators

  • Basilea Pharmaceutica

    collaborator INDUSTRY

  • Astellas Pharma Inc

    lead INDUSTRY

Principal Investigators

  • Medical Director · Astellas Pharma Global Development

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01406171 on ClinicalTrials.gov